Loading...
XKRX002210
Market cap70mUSD
Jan 09, Last price  
4,485.00KRW
1D
-2.82%
1Q
-0.99%
Jan 2017
7.04%
Name

Dongsung Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:002210 chart
P/E
—
P/S
1.16
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
4.05%
Rev. gr., 5y
-0.73%
Revenues
88.59b
-5.07%
60,319,470,00062,231,434,00068,724,160,00071,926,026,00078,442,097,85084,581,021,13075,175,284,43073,157,941,99074,660,371,33079,720,854,99082,385,233,76091,912,685,72086,536,755,32087,799,927,10084,407,657,78093,328,194,83088,593,588,700
Net income
-2.07b
L-2.25%
2,655,952,0003,656,617,000568,431,000-7,937,344,0001,701,094,0003,192,087,640-1,988,228,680-10,946,949,990454,837,700-1,660,443,190-198,264,210-5,744,557,940-8,385,204,520-14,079,137,960-4,312,832,260-2,121,670,410-2,073,909,512
CFO
-4.29b
L+10.58%
2,917,321,000-365,261,000-5,020,962,0004,634,814,000-2,643,336,7802,804,608,550-2,567,516,7203,650,150,210-9,319,457,650-3,344,347,6101,798,768,5501,393,269,480-8,305,940,9005,009,717,510-2,751,533,010-3,882,625,680-4,293,334,675
Dividend
Dec 27, 201330 KRW/sh

Profile

Dong Sung Bio Pharm.Co.,Ltd. engages in the pharmaceuticals, cosmetics, hair dye, and photodynamic therapy businesses in South Korea. It offers OTC drugs, such as liver disease treatment, climacterium, skin disease, obesity, digestive, gingival, alopecia, antipyretic, analgesic, anti-inflammatory, respiratory, scar-recovery, sleep inducer, antidiarrhotica, antiemetic, antiviral, blood circulation enhancer, antifungal, and anti-histamine drugs, as well as keratin softeners, optic nutrition supplements, and vitamins. The company also provides ETC drugs, including endocrine, gastrointestinal, circulatory, neuropsychologic, tumor, analgesic/anti-inflammation, dermato-urinary, anti-viral, antibiotic, antifungal, anti-histamine, and respiratory drugs, as well as steroids and eye drops. In addition, it offers hair dyeing agents, health functional foods, medical devices, daily supplies, muscle taping products, disinfectants, toothpastes, anti-hair loss and hair increase shampoos, sanitary pads, and other products. The company was founded in 1957 and is headquartered in Seoul, South Korea.
URL
http://dongsung-pharm.com/
IPO date
Jan 19, 1990
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
88,593,589
-5.07%
93,328,195
10.57%
Cost of revenue
78,049,771
84,225,173
Unusual Expense (Income)
NOPBT
10,543,818
9,103,022
NOPBT Margin
11.90%
9.75%
Operating Taxes
1,208,024
271,068
Tax Rate
11.46%
2.98%
NOPAT
9,335,794
8,831,954
Net income
(2,073,910)
-2.25%
(2,121,670)
-50.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,996,449)
BB yield
1.24%
Debt
Debt current
24,732,542
29,273,964
Long-term debt
18,635,270
7,865,999
Deferred revenue
Other long-term liabilities
8,538,137
7,272,511
Net debt
29,212,819
32,535,970
Cash flow
Cash from operating activities
(4,293,335)
(3,882,626)
CAPEX
(923,561)
(642,899)
Cash from investing activities
(927,713)
638,290
Cash from financing activities
7,567,354
4,240,224
FCF
8,300,757
(2,780,480)
Balance
Cash
6,435,381
4,093,782
Long term investments
7,719,611
510,212
Excess cash
9,725,313
Stockholders' equity
28,669,530
30,041,797
Invested Capital
81,887,949
86,698,843
ROIC
11.08%
10.31%
ROCE
11.11%
10.23%
EV
Common stock shares outstanding
23,910
24,182
Price
5,760.00
-13.77%
6,680.00
-20.29%
Market cap
137,721,876
-14.74%
161,534,985
-17.63%
EV
166,934,696
194,070,955
EBITDA
12,589,804
11,222,771
EV/EBITDA
13.26
17.29
Interest
2,240,914
1,307,811
Interest/NOPBT
21.25%
14.37%